New England Biolabs, Inc. Licenses Integrated Genomics, Inc.'s ERGO(TM) Genomics Platform to Identify Novel Enzymes and Biological Products in Microbes
5/14/2007 10:47:20 AM
CHICAGO & IPSWICH, Mass.--(BUSINESS WIRE)--New England Biolabs (NEB), a world leader in the production and supply of reagents for the life science industry, has licensed the ERGO™ bioinformatics software developed and maintained by Integrated Genomics. NEB will utilize the ERGO™ genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as for comparative genomics purposes.